The Chicago Entrepreneur

FTC sues drug middlemen for allegedly inflating insulin prices

The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group’s Optum Rx, CVS Health’s Caremark and Cigna’s Express Scripts.

Previous post The surprising math of immigration, Social Security and Medicare
Next post Trump Media & Technology Group’s stock hits low as insider stock-sale ban lifts